Next Generation Sequencing Market to Reach US$ 35.92 Billion by 2033 at 11.6% CAGR, Driven by Advances in Precision Medicine and Genomic Research | DataM Intelligence

According to DataM Intelligence, the global Next Generation Sequencing (NGS) market reached US$ 13.42 billion in 2024 and is expected to reach US$ 35.92 billion by 2033, growing at a CAGR of 11.6% during the forecast period 2025-2033, driven by rapid adoption in oncology, genetic screening, and drug discovery, expanding applications in whole genome and RNA sequencing, strong demand for reagents & consumables, and accelerating growth in Asia-Pacific with rising biotech investments.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/next-generation-sequencing-ngs-market?jd

Next Generation Sequencing Market Key Mergers and Acquisitions

✦ January 2026: Illumina Inc. acquired a genomics data analytics startup to enhance its sequencing platforms with advanced bioinformatics and cloud integration for precision medicine.
✦ December 2025: Thermo Fisher Scientific Inc. completed a strategic acquisition of a next-gen sequencing consumables firm to expand its reagent and library preparation portfolio for clinical diagnostics.
✦ November 2025: Qiagen secured a licensing agreement with an AI-driven variant interpretation provider to integrate real-time analysis into its NGS workflows for oncology and rare disease applications.

Next Generation Sequencing Market Key Industry Developments

☑️ January 2026: Thermo Fisher Scientific Inc., Illumina Inc., and Agilent Technologies, Inc. launched upgraded NGS instruments and reagents with higher throughput and lower error rates, securing major contracts for clinical diagnostics and drug discovery in North America.
☑️ December 2025: Bio-Rad Laboratories, Inc. and Qiagen expanded their NGS consumables and library prep kits with improved compatibility for whole genome and RNA sequencing, targeting academic research institutes and biotech firms.
☑️ November 2025: Revvity (PerkinElmer Inc.) and Takara Bio Inc. introduced new sequencing panels for genetic screening and agriculture research, gaining adoption in Asia-Pacific for high-resolution variant detection.

Purchase the report to unlock market insights:
https://www.datamintelligence.com/buy-now-page?report=next-generation-sequencing-ngs-market

Next Generation Sequencing Market Segmentation Analysis

By Product Type: Reagents and Consumables hold the largest share due to recurring high-volume usage in library preparation, sequencing, and data analysis; Instruments grow steadily for new high-throughput platforms; Others include software and bioinformatics tools.

By Application: Drug Discovery and Diagnostics account for major demand with NGS enabling targeted therapies and companion diagnostics; Genetic Screening grows rapidly for hereditary disease and prenatal testing; Agriculture and Animal Research expands for genomic selection; Others include oncology research and infectious disease surveillance.

By Technology: Whole Genome Sequencing dominates with comprehensive variant detection; RNA Sequencing and Methyl Sequencing follow for transcriptomics and epigenetics; Chip Sequencing, De Novo Sequencing, and Others grow for specialized studies.

By End-User: Biotechnology and Pharmaceutical Companies lead for drug discovery and development; Hospitals and Diagnostic Centers grow with clinical NGS adoption; Academic & Research Institutes expand for fundamental genomics research; Others include CROs and government labs.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/next-generation-sequencing-ngs-market?jd

Next Generation Sequencing Market Key Players

✦ Thermo Fisher Scientific Inc. - In January 2026, launched upgraded NGS instruments and reagents with higher throughput and lower error rates for clinical diagnostics and drug discovery applications.
✦ Illumina Inc. - Acquired a genomics analytics startup in January 2026 and introduced next-gen sequencing platforms with enhanced bioinformatics integration for precision medicine and oncology research.
✦ Agilent Technologies, Inc. - Expanded NGS library prep and target enrichment kits in late 2025 with improved compatibility for whole genome and RNA sequencing in biotech and academic labs.
✦ Qiagen - Rolled out advanced NGS panels in December 2025 for genetic screening and infectious disease detection, strengthening its clinical and research offerings.
✦ Revvity (PerkinElmer Inc.) - Introduced new sequencing solutions in November 2025 with focus on high-resolution variant detection for agriculture and rare disease research.

Next Generation Sequencing Market Regional Insights

North America commands the largest market share in the global Next Generation Sequencing market, supported by advanced genomics research infrastructure, high adoption in oncology and drug discovery, strong reimbursement for clinical NGS, significant R&D investment by leading biotech and pharma companies, and presence of major sequencing providers driving innovation in reagents, instruments, and bioinformatics.

Asia-Pacific is the fastest-growing region, fueled by rapid expansion of biotechnology and pharmaceutical industries in China, India, and Japan, increasing investments in genomic research and precision medicine, growing clinical diagnostics and genetic screening applications, government initiatives for healthcare innovation, and aggressive adoption of NGS platforms by research institutes and hospitals.

Unlock 360° Market Intelligence with DataM Intelligence Subscription Services:
https://www.datamintelligence.com/reports-subscription?jd

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.